Prolonged treatment-free remission in chronic myeloid leukemia patients with previous BCR-ABL1 kinase domain mutations

被引：8
|
作者：
Claudiani, Simone [1 ,2 ]
Apperley, Jane F. [1 ,2 ]
Khan, Afzal [2 ]
Khorashad, Jamshid [2 ]
Milojkovic, Dragana [1 ]
机构：
[1] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, Dept Haematol, London, England
[2] Imperial Coll London, Hammersmith Hosp, Dept Immun & Inflammat, Ctr Haematol,Fac Med, London, England
来源：
HAEMATOLOGICA | 2020年 / 105卷 / 05期
关键词：
MOLECULAR RESPONSE; CLINICAL-PRACTICE; INHIBITORS; IMATINIB; DISCONTINUATION; RECOMMENDATIONS; GUIDELINES; DASATINIB;
D O I：
10.3324/haematol.2019.234179
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E225 / E227
页数：3
相关论文
共 50 条
  • [1] Reflexive Screening for BCR-ABL1 Kinase Domain Mutations in Chronic Myeloid Leukemia
    Langabeer, Stephen E.
    McCarron, Sarah L.
    Haslam, Karl
    Preston, Lisa
    CLINICAL LABORATORY, 2016, 62 (05) : 975 - 976
  • [2] Mutations in the BCR-ABL1 Kinase Domain and Elsewhere in Chronic Myeloid Leukemia
    Soverini, Simona
    de Benedittis, Caterina
    Mancini, Manuela
    Martinelli, Giovanni
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S120 - S128
  • [3] BCR-ABL1 Kinase Domain Mutation Analysis in an Irish Cohort of Chronic Myeloid Leukemia Patients
    McCarron, Sarah L.
    O'Connor, Lisa M.
    Langabeer, Stephen E.
    Conneally, Eibhlin
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2013, 17 (02) : 170 - 173
  • [4] Impact of BCR-ABL1 Transcript Type on Response, Treatment-Free Remission Rate and Survival in Chronic Myeloid Leukemia Patients Treated with Imatinib
    Marce, Silvia
    Xicoy, Blanca
    Garcia, Olga
    Cabezon, Marta
    Estrada, Natalia
    Velez, Patricia
    Boque, Concepcion
    Sagues, Miguel
    Angona, Anna
    Teruel-Montoya, Raul
    Ferrer-Marin, Francisca
    Amat, Paula
    Hernandez-Boluda, Juan Carlos
    Ibarra, Mariana M.
    Anguita, Eduardo
    Cortes, Montserrat
    Fernandez-Ruiz, Andres
    Fontanals, Sandra
    Zamora, Lurdes
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (14)
  • [5] Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors
    Erbilgin, Yucel
    Eskazan, Ahmet Emre
    Ng, Ozden Hatirnaz
    Salihoglu, Ayse
    Elverdi, Tugrul
    Firtina, Sinem
    Tasar, Orcun
    Mercan, Sevcan
    Sisko, Sinem
    Khodzhaev, Khusan
    Ongoren, Seniz
    Ar, Muhlis Cem
    Baslar, Zafer
    Soysal, Teoman
    Sayitoglu, Muge
    Ozbek, Ugur
    LEUKEMIA & LYMPHOMA, 2019, 60 (01) : 200 - 207
  • [6] BCR-ABL1 tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia
    Cuellar, Sandra
    Vozniak, Michael
    Rhodes, Jill
    Forcello, Nicholas
    Olszta, Daniel
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (06) : 433 - 452
  • [7] Second Treatment-Free Remission Attempt in Patients with Chronic Myeloid Leukemia
    Ureshino, Hiroshi
    Kamachi, Kazuharu
    Kimura, Shinya
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (04) : e138 - e141
  • [8] BCR-ABL1 transcript doubling time as a predictor for treatment-free remission failure after imatinib discontinuation in chronic myeloid leukaemia in chronic phase
    Hwan Kim, Dennis Dong
    Simon Kim, Taehyung
    Atenafu, Eshetu G.
    Novitzky Basso, Igor
    Forrest, Donna
    Bence-Bruckler, Isabelle
    Savoie, Lynn
    Busque, Lambert
    Keating, Mary-Margaret
    Delage, Robert
    Xenocostas, Anargyros
    Liew, Elena
    Paulson, Kristjan
    Stockley, Tracy
    Laneuville, Pierre
    Lipton, Jeffrey H.
    Kamel-Reid, Suzanne
    Leber, Brian
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (01) : 136 - 145
  • [9] Treatment-free remission in patients with chronic myeloid leukemia
    Rea, Delphine
    Cayuela, Jean-Michel
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2018, 108 (04) : 355 - 364
  • [10] Comparison of Frequency and Sensitivity of BCR-ABL1 Kinase Domain Mutations in Asian and White Patients With Imatinib-resistant Chronice-Phase Chronic Myeloid Leukemia
    Kim, Hawk
    Kim, SooHyun
    Kim, Hyeoung-Joon
    Kim, Yeo-Kyeoung
    Kwak, Jae-Yong
    Yhim, Ho-Young
    Kim, Sung-Hyun
    Do, Young Rok
    Oh, Sukjoong
    Lee, Sung-Eun
    Jootar, Saengsuree
    Cui, Jiu Wei
    Kim, Dong-Wook
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (10) : E391 - E399
12345